Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potiga in Amyotrophic Lateral Sclerosis
NCT02450552Phase 2Completed
- Start
- Jun 2015
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
A Phase 2 trial of retigabine in amyotrophic lateral sclerosis (ALS). Started Jun 2015; status: completed.
02
Drugs
retigabine
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT02450552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02450552.